Stevenage, United Kingdom

Helen Elizabeth Aylott


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Helen Elizabeth Aylott: Innovator in Pharmaceutical Compounds

Introduction

Helen Elizabeth Aylott is a notable inventor based in Stevenage, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as bromodomain inhibitors. With a total of 2 patents to her name, Aylott's work is recognized for its potential therapeutic applications.

Latest Patents

Aylott's latest patents include the invention of pyridinone dicarboxamide for use as bromodomain inhibitors. The present invention relates to compounds of formula (I) and salts thereof, as well as pharmaceutical compositions containing such compounds and their use in therapy. This innovative work highlights her commitment to advancing medical science.

Career Highlights

Helen Elizabeth Aylott is associated with GlaxoSmithKline Intellectual Property (No. 2) Limited, where she continues to contribute to groundbreaking research and development in the pharmaceutical industry. Her expertise and dedication have positioned her as a valuable asset in her field.

Collaborations

Aylott has collaborated with esteemed colleagues such as Stephen John Atkinson and Anthony William James Cooper. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of her work.

Conclusion

Helen Elizabeth Aylott stands out as a prominent inventor in the pharmaceutical sector, with her innovative patents paving the way for future advancements in therapy. Her contributions are a testament to her expertise and dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…